Le Lézard
Classified in: Health
Subjects: AWD, CSR

Nicklaus Children's Announces $15 Million Gift from South Florida Philanthropists Helen and Jacob Shaham


This significant gift will elevate care so no family has to leave the state for expert pediatric cancer treatment

MIAMI, April 4, 2024 /PRNewswire/ -- Nicklaus Children's Hospital today announced a $15 million gift from South Florida philanthropists Helen and Jacob Shaham to further elevate world-class pediatric cancer care and research through the hospital's cancer and blood disorders institute. In recognition of the gift, the program now proudly bears the name, the Helen & Jacob Shaham Cancer & Blood Disorders Institute.

Helen and Jacob Shaham founded The Palace Group in 1980. The family-owned and operated business focuses on providing luxury living for seniors across South Florida. And now, the Shahams' generous gift will ensure world-class pediatric cancer care for the patients and communities served by Nicklaus Children's.

"We are incredibly thankful to Helen and Jacob Shaham for their remarkable generosity and commitment to the children and families of our community," said Matthew A. Love, president and CEO of Nicklaus Children's Health System, parent organization of the hospital. "Their naming gift will be transformational for children with cancer and blood disorders, helping us advance our mission to inspire hope and promote lifelong health by providing the best care to every child."

 "My father-in-law died from cancer," said Jacob Shaham. "My identical twin brother died from cancer two years ago. It's close to us. For the last 45 years, we did everything for our elderly residents; now, it's time to do something for our youngest residents. Thank you for allowing us to belong to this hospital. Thank you for allowing us to be in your family."

The naming gift was announced during a reception at the hospital attended by the Shahams, their family and friends, community leaders, and hospital leaders and supporters. During the event, a sign bearing the new institute name was unveiled in the cancer and blood disorders unit on the sixth floor of the Advanced Pediatric Care Pavilion.

The gift will elevate pediatric cancer care and research so no child ever has to leave the state for treatment and enhance the hospital's standing as leading cancer care provider for children through investments in groundbreaking research focused on new cures, treatments and diagnostic procedures.

The Shaham gift is the first gift to name a Nicklaus Children's Hospital clinical institute. It is the second transformational gift to Nicklaus Children's as part of the hospital's comprehensive campaign to invest in the future of pediatric care, Forward For Generations. Last year, Citadel founder and CEO Ken Griffin donated $25 million to the campaign, naming the Kenneth C. Griffin Surgical Tower which opens this summer.

To learn more about supporting Nicklaus Children's Hospital, please visit http://give.nicklauschildrens.org  

About Nicklaus Children's Hospital, Where Children Matter Most
Founded in 1950 by Variety Clubs International, Nicklaus Children's Hospital is South Florida's only licensed specialty hospital exclusively for children, with approximately 850 attending physicians, including more than 500 pediatric subspecialists. The 307-bed hospital is renowned for excellence in all aspects of pediatric medicine with many specialty programs routinely ranked among the best in the nation by U.S. News & World Report since 2008. The hospital is also home to the largest pediatric teaching program in the southeastern United States and since 2003 has been designated an American Nurses Credentialing Center (ANCC) Magnet facility, the nursing profession's most prestigious institutional honor. For more information, please visit www.nicklauschildrens.org

MEDIA CONTACT:  
Rachel Perry Bixby
Nicklaus Children's Hospital
[email protected] 
305-898-9165

SOURCE Nicklaus Children's Hospital


These press releases may also interest you

at 05:05
Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Dale Levitzke as CEO with immediate effect, as Dr. Frank F. Craig, current CEO and co-founder,...

at 05:05
Scenic Biotech, a pioneer in the field of modifier therapies for severe genetic disorders, today announced that it has entered into a research collaboration with Bristol Myers Squibb to accelerate the development of Bristol Myers Squibb's drug...

at 05:00
As PetSafe® continues to lead the way in pet-tech innovations, we are proud to introduce the next evolution in pet fountains: the PetSafe® Outlasttm 90 oz Pumpless Pet Fountain with patented HydroSpintm technology....

at 05:00
BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany. The main objective of the project is to develop novel immunotherapeutic strategies to...

at 04:52
Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been dosed in its Phase 1 clinical trial of FP-020 in Australia. The Phase 1 clinical trial is a randomized, double-blind, placebo-controlled,...

at 04:09
A news report from China Daily: The 2024 ZGC Forum in Beijing showcased a wide range of latest technological innovations. The event ran from April 25 to 29 and comprised 128 activities, including forums and conferences, technology exchanges,...



News published on and distributed by: